TAVI at TCT 2012: Climbing the learning curve and making way for improvement

Wed, 10/24/2012 - 5:46pm
Mass Device

Transcatheter aortic valve implantation systems figure large in studies presented at the Transcatheter Cardiovascular Therapeutics conference this week, with researchers reporting ever-improving outcomes and looking for ways to improve the field.

TCT 2012 logo

 TAVI registries showing greater success with experience, upgrades
As European clinics gain experience and new TAVI systems incorporate design improvements, the rates of procedure-related complications are sinking fast, according to registry data.  

Researchers provided updates from the Source/Source XT, Prevail XT, and France 2 registries during the TCT conference, TCT Daily reported.

Dr. Martyn Thomas of St. Thomas' Hospital in London announced that major complications associated with TAVI had gone down between the Source studies of Edwards Lifesciences' (NYSE:EW) Sapien device and the Source XT studies of the Sapien XT device, which features a cobalt-chromium frame and additional valve sizing.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.